Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference26 articles.
1. Cancer of the Urinary Bladder—SEER Stat Fact Sheets [Internet]. Disponible en: https://seer.cancer.gov/statfacts/html/urinb.html. Accessed 5 de noviembre de 2016.
2. Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance Bacillus Calmette-Guérin. Eur Urol. 2016;69(1):60–9.
3. Soulières D, Greer W, Magliocco AM, Huntsman D, Young S, Tsao M-S, et al. KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies. Curr Oncol. 2010;17(Suppl 1):S31–40.
4. Jiricny J. Mediating mismatch repair. Nat Genet. 2000;24(1):6–8.
5. Slee EA, O’Connor DJ, Lu X. To die or not to die: how does p53 decide? Oncogene. 2004;23(16):2809–18.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献